These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 4193195

  • 1. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
    Mori T, Fisher J, Kriss JP.
    J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L, Uthgenannt H, Schemmel K, Müller W, Heesen H, Eickenbusch W, Bindeballe W.
    Med Klin; 1966 Dec 30; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract] [Full Text] [Related]

  • 4. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
    Depisch D, Höfer R, Schatz H.
    Wien Z Inn Med; 1968 Dec 30; 49(11):418-22. PubMed ID: 5737591
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
    Bonnyns M, Vanhaelst L.
    J Endocrinol; 1969 Jan 30; 43(1):125-6. PubMed ID: 4886576
    [No Abstract] [Full Text] [Related]

  • 6. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
    Adlkofer F, Schleusener H, Uher L, Ananos A.
    Acta Endocrinol (Copenh); 1973 Jul 30; 73(3):483-8. PubMed ID: 4740843
    [No Abstract] [Full Text] [Related]

  • 7. The interaction between thyroid tissue and the long-acting thyroid stimulator.
    Kendall-Taylor P, Smith BR, Munro DS.
    Q J Med; 1971 Oct 30; 40(160):564-5. PubMed ID: 4110160
    [No Abstract] [Full Text] [Related]

  • 8. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J, Takó J, Bános C, Gesztesi E, Varga I.
    Acta Med Acad Sci Hung; 1969 Oct 30; 26(3):233-43. PubMed ID: 5395883
    [No Abstract] [Full Text] [Related]

  • 9. Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulins.
    Yagi H, Takeuchi M, Nagashima K, Suzuki S, Kuroume T, Iida Y, Konishi J, Endo K.
    J Pediatr; 1983 Oct 30; 103(4):591-3. PubMed ID: 6137525
    [No Abstract] [Full Text] [Related]

  • 10. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
    Földes J, Takó J, Bános C, Gesztesi E, Juhász J.
    Acta Endocrinol (Copenh); 1973 Dec 30; 74(4):675-84. PubMed ID: 4800904
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro.
    Wong ET, Litman GW.
    J Clin Endocrinol Metab; 1969 Jan 30; 29(1):72-8. PubMed ID: 5762323
    [No Abstract] [Full Text] [Related]

  • 12. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L, Uthgenannt H, Schemmel K, Müller W, Heesen H, Eickenbusch W, Bindeballe W.
    Schweiz Med Wochenschr; 1967 Jul 15; 97(28):898-904. PubMed ID: 5587446
    [No Abstract] [Full Text] [Related]

  • 13. Comparative effects of immunization of rabbits with human thyroglobulin and human and rabbit thyroid microsomal fractions.
    Beall GN, Chopra IJ, Solomon DH.
    Clin Exp Immunol; 1971 Apr 15; 8(4):647-56. PubMed ID: 5576294
    [Abstract] [Full Text] [Related]

  • 14. Antibody nature of the long-acting thyroid stimulator.
    Földes J, Takõ J, Bãnos C, Gesztesi E.
    Acta Med Acad Sci Hung; 1971 Apr 15; 28(3):313-9. PubMed ID: 5154552
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discrepancy between inactivation by thyroid particulate fraction and thyroid stimulating activity of long-acting thyroid stimulator (LATS).
    Shishiba Y, Shimizu T, Yoshimura S, Shizume K.
    J Clin Endocrinol Metab; 1972 Jan 15; 34(1):7-12. PubMed ID: 5061777
    [No Abstract] [Full Text] [Related]

  • 17. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
    Orgiazzi J, Pousset G, Durand H.
    Presse Med (1893); 1971 May 22; 79(25):1167-8. PubMed ID: 4933634
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
    Benhamou-Glynn N, el-Kabir DJ, Doniach D, Roitt IM.
    Proc R Soc Med; 1968 Dec 12; 61(12):1303-5. PubMed ID: 4178461
    [No Abstract] [Full Text] [Related]

  • 19. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
    Mori T, Kriss JP.
    J Clin Endocrinol Metab; 1971 Oct 12; 33(4):688-98. PubMed ID: 5109861
    [No Abstract] [Full Text] [Related]

  • 20. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
    Adams DD, Kennedy TH.
    J Clin Endocrinol Metab; 1967 Feb 12; 27(2):173-7. PubMed ID: 4163610
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.